• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Exercise therapy beneficial for some ME/CFS patients new Cochrane report says

biophile

Places I'd rather be.
Messages
8,977
Cochrane said:
Two studies (Wearden 2010; White 2011) referenced published protocols, and when we checked these against the published results, we found that reporting was adequate. In one study (Wearden 1998), trial investigators reported numerical data for only one subscale (health perception) of the Medical Outcomes Survey (MOS) scale (Ware 1992), for which data favour the intervention group; no numerical data were given for the five other subscales, nor for another scale (anxiety), as data were "similar in trial completers." It was not possible to check the other studies for selective reporting bias; therefore their risk of bias is considered unclear.

user9876 said:
I know many of us have read toe protocol and compared what is published to the original protocol and with PACE it is largely different (maybe just things like the scoring process for the CFQ but different). So it surprises me that they say they have checked it and reporting is adequate. I suspect they are only referring to the measures used in their meta analysis but this still seems like a very sloppy piece of work. Maybe Cochrane accept that a clinical protocol can be rewritten for a non-blinded trial?

Good point. Coincidently though, Wearden and White were both co-authors of the protocol for the Cochrane review:

http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011040/full

[edit: not co-authors of this review, but co-authors of an accompanying review of individual patient data, see posts below]
 
Last edited:

Dolphin

Senior Member
Messages
17,567

biophile

Places I'd rather be.
Messages
8,977
That's the individual patient data review which, as I understand it, is different (I haven't looked at the new review yet).

Oops, OK, thanks. Found this from the current review in question:

This review, which is an update of a Cochrane review first published in 2004, will update the evidence base that serves as a resource for informed decision making by healthcare personnel and patients. A protocol for an accompanying individual patient data review on chronic fatigue syndrome and exercise therapy has been published (Larun 2014).

http://onlinelibrary.wiley.com/enhanced/doi/10.1002/14651858.CD003200.pub3
 

user9876

Senior Member
Messages
4,556
Good point. Coincidently though, Wearden and White were both co-authors of the protocol for the Cochrane review:

http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011040/full

[edit: not co-authors of this review, but co-authors of an accompanying review of individual patient data, see posts below]

As you have said it is a different review. This is a review that updates a previous version (from 2004). However it is very sympathetic to those pushing GET since it uses subjective measures as the main outcomes and doesn't look at compliance to treatment (ok I've not read it all yet) or more objective measures.

Basically as a review it blindly accepts flawed methodologies and measures in the original papers and looks at their preferred results.
 

beaker

ME/cfs 1986
Messages
773
Location
USA
I'm going to propose a simple thought experiment to make the logical structure of arguments about questionable therapeutic approaches to diseases of unknown etiology clearer. Where you see the proposed therapy mentioned, substitute "painting patients blue". (This is particularly appropriate for studies done in the British Isles, where there is a real historical background for the practice. See Caesar's Commentarii de Bello Gallico.) Where you read "without adverse effects" substitute "without killing them" or "nobody died". Where you find a purely subjective evaluation of results, substitute "we thought this looked quite attractive."

This reduces the PACE trial to "We investigated the approach of painting patients blue, and found this could be done without killing them. After detailed analysis we concluded that we all thought this looked quite attractive."
Thanks I needed that !!
 

Dolphin

Senior Member
Messages
17,567
Third PubMed Commons comment http://www.ncbi.nlm.nih.gov/pubmed/25674924#cm25674924_9229
Laurie Thomas
2015 Feb 24 11:58 a.m. (7 days ago)

Clinical studies of chronic fatigue syndrome are plagued by serious problems in the inclusion/exclusion criteria. These problems stem from the fact that the syndrome consists of nonspecific symptoms that are "medically unexplained." However, there is a major difference between medically unexplained and medically inexplicable. The symptoms of chronic fatigue syndrome can result from a serious circulatory problem that is easily overlooked. In 2003, Peckerman and coworkers showed that low cardiac output, as measured by impedance cardiography, predicts the severity of symptoms in CFS patients.[1] Miwa and Fujita found a small left ventricular size leading to low cardiac output in CFS patients with orthostatic intolerance.[2] Porter and coworkers reported that a case of femoral arteriovenous fistula causing high-output cardiac failure was originally misdiagnosed as chronic fatigue syndrome.[3]

The studies of graded exercise for management of CFS are based on the presumption that CFS is the result of laziness and deconditioning and that the solution to the problem is to persuade the patient to exercise. Yet in many reported cases, the real problem was unrecognized cardiac decompensation. This state of cardiac decompensation could account for the push-crash phenomenon (serious, prolonged adverse events from overexertion) among people with CFS. Thus, a graded exercise program that might be beneficial for the large number of people who are tired and achy because of major depressive disorder could be catastrophic for the relatively small number of people whose problem is due to cardiac decompensation. Unfortunately, the existing studies of exercise for management of CFS do not shed light on this problem. The patients whose exercise intolerance is too severe to allow them to participate in the exercise program might refuse to enroll or might be dismissed as noncompliant if they try but fail to exercise. Yet as a result of the positive results of graded exercise for subjects whose real problem is major depressive disorder, patients with unrecognized cardiac decompensation are being scolded for failing to exercise.

For ethical and scientific reasons, the protocol for a clinical study of subjects with CFS should be based on the best possible model for clinical management of CFS patients. It would begin with a careful assessment of the subject's circulatory status. This assessment should include a tilt-table test, or at least a measurement of supine, sitting, and standing pulse and blood pressure. Any circulatory problem should be addressed appropriately. (Note that once the patient's condition is found to be due to a circulatory problem, the patient no longer fits the inclusion criteria of "medically unexplained" symptoms.)

As improper diet is the most prevalent cause of chronic ill-health, the cardiology assessment should be followed by a run-in period of at least a week of optimal dietary management. Subjects should be fed a low-fat (<10% of calories), purely plant-based diet that excludes the most common causes of food allergies or intolerance syndromes (i.e., wheat, rye, barley, corn, soy, strawberries, and citrus fruits). To ensure adherence, the diet should be administered in a residential setting. This kind of low-fat, plant-based diet can bring about a significant drop in blood pressure in hypertensive patients within 7 days, even if the patients stop taking blood pressure medication at baseline.[4] This correction of hypertension results from the decrease in systemic resistance. Thus, this diet could lead to a significant improvement in circulation, which would be beneficial to patients whose symptoms are due to poor circulation, even if they are not hypertensive. Note also that the elimination of poorly tolerated foods is the only reliable way to establish that the patient's problem is due to a food intolerance. Of course, once the subject's problem has been shown to be dietary in origin, the subject no longer has "medically unexplained" symptoms and thus no longer fits the inclusion criteria for a study of CFS.

Many patients with a diagnosis of CFS are inactive, but they may be inactive because they are sick, rather than being sick because they are inactive. Thus, any study of exercise and CFS should be structured to establish the direction of causality. If a study of subjects with a diagnosis of CFS involves exercise, the outcome variables must involve some measurement of the subjects' overall activity levels, not just to assess compliance with the exercise program but to assess whether the subjects are merely wasting their energy on the exercises and thus become less able to perform activities of daily living. In that situation, the exercise program could actually decrease the subject's quality of life.

[1] Peckerman A, LaManca JJ, Dahl KA, Chemitiganti R, Qureishi B, Natelson BH. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am J Med Sci. 2003 Aug;326(2):55-60.

[2] Miwa K1, Fujita M. Small heart with low cardiac output for orthostatic intolerance in patients with chronic fatigue syndrome.Clin Cardiol. 2011 Dec;34(12):782-6. doi: 10.1002/clc.20962. Epub 2011 Nov 28.

[3] Porter J1, Al-Jarrah Q1, Richardson S. A case of femoral arteriovenous fistula causing high-output cardiac failure, originally misdiagnosed as chronic fatigue syndrome. Case Rep Vasc Med. 2014;2014:510429. doi: 10.1155/2014/510429. Epub 2014 May 20.

[4] McDougall J1, Thomas LE, McDougall C, Moloney G, Saul B, Finnell JS, Richardson K, Petersen KM.Effects of 7 days on an ad libitum low-fat vegan diet: the McDougall Program cohort. Nutr J. 2014 Oct 14;13:99. doi: 10.1186/1475-2891-13-99.
 

Dolphin

Senior Member
Messages
17,567
The letter has been published in Therapy Today which “is the flagship professional journal published by British Association for Counselling and Psychotherapy (BACP), the largest membership organisation for counsellors and psychotherapists in the UK with over 40,000 members.”

Well done, and thanks, to Joan.

http://therapytoday.net/article/show/4716/activity-and-chronic-fatigue-syndrome/

==


Activity and chronic fatigue syndrome by Joan Crawford


In the February 2015 edition of Therapy Today (News, p6) there is a short report on exercise and CFS. Uncritically your report states, ‘Both [CBT aimed at increasing patients activity and GET (graded exercise therapy)] have been shown to be beneficial to people with CFS.’ The evidence base does not support this bold assertion.


In a recent Cochrane Review 1 of the eight clinical trials of GET (n=1518) 85 per cent of the patients (n=1287) were recruited into five of these trials based on one symptom – fatigue.2 This is a common symptom of many health problems, including major depression, making generalisation of the findings problematic. The high percentage of patients included in these trials with elevated levels of distress perhaps indicating a depressive state,1 which may be their primary condition, confounds the results. Exercise, through behavioural activation programmes, has a moderately positive impact on patients with depression.3 It is unclear whether the modest improvement seen in some of these trials can be accounted for by an improvement in low mood caused by depression. Moreover, where there are data, there is a high usage of antidepressants in patients included in trials. Three further trials used the CDC4 CFS criteria (n=231). While these criteria purport to be more selective, they do not necessarily include patients whose primary difficulties include post-exertion weakness and debility beyond broadly defined fatigue and other general symptoms, that could be attributed to CFS or major depression.


There is also an issue with lack of evidence of patients’ fidelity to exercise programmes using objective measures. Without using monitoring devices such as actimeters or pedometers to track daily activity levels, we have no accurate way of assessing whether an increase in activity occurred and whether this helps. Black and McCully’s study5 demonstrates the difficulties CFS patients face when trying to increase activity and concluded that they were exercise intolerant, unable to sustain activity targets.


Many patient surveys from across the world report numerous instances of harm and worsening of symptoms from taking part in exercise programmes. For a summary of the difficulties and limitations of the reporting of harms, in and outside of clinical trials, and why these might be underestimated, please see Kindlon.6


Joan Crawford MA, MSc, CSci, MBPS, MBABCP

Chair, Chester ME self help (MESH);

Humanistic counsellor, CBT therapist and trainee counselling psychologist


References:

1. Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Systematic Review 2015. http://www.ncbi.nlm.nih.gov/pubmed/25674924

2. Sharpe M, Archard L, Banatvala J et al. Chronic fatigue syndrome: guidelines for research. Journal of the Royal Society of Medicine 1991; 84(2):118–121.

3. Cooney GM, Dwan K, Greig CA et al. Exercise for depression. The Cochrane Library 2013. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004366.pub6/abstract

4. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 1994; 121(12): 953–959.

5. Black CD, McCully KK. Time course of exercise induced alterations in daily activity in chronic fatigue syndrome. Dynamic Medicine 2005; 28(4):10.

6. Kindlon T. Reporting of harms associated with graded exercise therapy and cognitive behavioural therapy in Myalgic Encephalomyelitis/chronic fatigue syndrome. Bulletin of the IACFS/ME 2011; 19(2): 59–111.


See more at: http://therapytoday.net/article/sho...hronic-fatigue-syndrome/#sthash.al2Ajmjx.dpuf
 

Dolphin

Senior Member
Messages
17,567
I've started to make my way through it.

Can't remember what was said in this thread but they don't report on any objective measures e.g. 6-minute walking test, fitness test, exercise test, employment data, etc. Very frustrating.
 

Dolphin

Senior Member
Messages
17,567
Acknowledgements

We would like to thank Peter White and Paul Glasziou for advice and additional information provided. We would also like to thank Kathy Fulcher, Richard Bentall, Alison Wearden, Karen Wallman and Rona Moss-Morris for providing additional information from trials in which they were involved, as well as the CCDAN editorial base for providing support and advice and Sarah Dawson for conducting the searches. In addition, we would like to thank Jane Dennis, Ingvild Kirkehei, Hugh McGuire and Melissa Edmonds for their valuable contributions, and Elisabet Hafstad for assistance with the search.
So Peter White was consulted not just for additional information about the trials they did but for advice.

I wonder would this be that common in Cochrane reviews of drugs i.e. that they'd contact a representative of a drug company about one of their drugs for "advice".
 

Dolphin

Senior Member
Messages
17,567
The authors of this review:
Exercise therapy for chronic fatigue syndrome (Review)
Larun L, Brurberg KG, Odgaard-Jensen J, Price JR

have been working with:
Larun L, Odgaard-Jensen J, Brurberg K, Chalder T, Dybwad M, Moss-Morris RE, Sharpe M, Wallman K, Wearden A, White PD, Glasziou PP
Exercise therapy for chronic fatigue syndrome (individual patient data)
http://www.cochrane.org/CD011040/DE...onic-fatigue-syndrome-individual-patient-data

This might make them less likely to be critical of their trials/work/etc.
 

Dolphin

Senior Member
Messages
17,567
1.4 Physical functioning

[..]

Four trials (669 participants) contributed data for evaluation of physical functioning at follow-up (Jason 2007; Powell 2001; Wearden 2010; White 2011). Jason 2007 observed better results among participants in the relaxation group (MD 21.48, 95% CI 5.81 to 37.15). However, results were distorted by large baseline differences in physical functioning between the exercise and relaxation groups (39/100 vs 54/100); therefore we decided not to include these results in the meta-analysis. Pooling of the three remaining trials (621 participants) showed a mean improvement on the SF-36 physical functioning subscale that was 16.33 points higher for exercise than for treatment as usual (95% CI -4.08 to 36.74; Analysis 1.6), but heterogeneity was excessive (I² = 96%, P value < 0.00001); therefore little or no difference cannot be ruled out.
This seems very unsatisfactory. They excluded the study where exercise did worse (a better thing, which still wouldn't be perfect) would be to look at the change (improvement/disimprovement) which was bigger in the non-exercise group (or to request the data and control for the baseline score/use baseline score as a covariate).
 

Dolphin

Senior Member
Messages
17,567
Serious adverse reactions were rare in both groups (RR 0.99, 95% CI 0.14 to 6.97; one study, 319 participants; moderate-quality evidence), but sparse data made it impossible for review authors to draw conclusions.

Peter White, DJ Clauw, MD, JWM van der Meer MD R Moss-Morris PhD, RR Taylor PhD spun the Cochrane results a different way in a comment to the journal, Annals of Internal Medicine
Secondly, there is little evidence of harm caused by graded exercise therapy (GET); a Cochrane systematic review of eight trials of exercise therapy for chronic fatigue syndrome (CFS), published this year, concluded that “..no evidence suggests that exercise therapy may worsen outcomes.”

There was not good reporting of harms in the eight trials PD White et al. refer to (at best one could say there was good reporting in one, the PACE trial) so it's misleading to talk about eight trials. Average scores don't tell one whether some people disimproved or not.
 

Dolphin

Senior Member
Messages
17,567
Exercise therapy did not worsen symptoms for people with CFS*. Serious side effects were rare in all groups, but limited information makes it difficult to draw firm conclusions about the safety of exercise therapy.
*They mean on average. That's not how one measures harms generally.